The characteristics of acute rejection after limb allotransplantation in rats—An experimental study

Abstract

To study the characteristics of acute rejection after limb allotransplantation, 29 male Sprague-Dawley rats were randomly divided into 2 groups, with 15 rats in control group and 14 rats in experimental group. Each rat in control group underwent limb replantation. Each rat in experimental group received limb transplantation from Wistar rat. No immnosuppressive drugs were used after operation. The circulation of the transplanted limb, time and signs of rejection, histopathological changes in the tissues of the limb graft when rejected and survival time of limb grafts were evaluated. In the control group, no signs of rejection were observed, the circulation of each replanted limb was normal, it could survive for a longer time. The experimental group showed clinical signs of rejection (sub dermal edema and erythema) after a mean time of 3.36±1.15 days, and the mean survival time of the allografts was only 7±0.78 days. Histopathological examination showed most violent rejection reaction in skin. It is concluded that with Wistar-to-SD limb transplantation without use of immunosuppression, rejection of the grafts would occur after a mean time of 3, 36±1, 15 days; the earliest signs of rejection were edema and erythema of the skin, being the most representative component of limb graft rejection.

Keywords

limb-allotransplantation / acute rejection

References

[1] BüttermeyerR, RaoU, ZhaoM, et al.. Rejection of the component tissues of limb allografts in rats immunosuppressed with FK506 and cyclosporine. Plast Reconstr Surg, 1996, 97: 139-139

[2] LeeW P A, YaremehukM J, PanY C, et al.. Relative antigenicity of components of a vascularized limb allograft. Plast Reconstr Surg, 1991, 87: 401-401

[3] HotokebuchiT, AraiK, TakagishiK, et al.. Limb allografts in rats immunosuppressed with cyclosporin: As a whole joint allograft. Plast Reconstr Surg, 1989, 83: 1027-1027

[4] BillinghamM E, CaryN R B, HammondM E, et al.. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. J Heart Transpl, 1990, 9: 587-587

[5] HewittC W, BlackK S, FraserL A, et al.. Cyclosporin A is superior to prior to donor-specific blood (DSB) transfusion for the extensive prolongation of rat limb allograft survival. Transpl Proc, 1983, 15: 514-514

[6] HewittC W, BlackK S, FraserL A, et al.. Composite tissue (limb) allografts in rats. I Dose dependent increase in survival with Cyclosporin. Transplantation, 1985, 39: 360-360

[7] BlackK S, HewittC W, FraserL A, et al.. Composite tissue (limb) allograft in rats. II. Indefinite survival using low dose Cyclosporin. Transplantation, 1985, 39: 365-365

[8] KimS K, AzizS, OyerP, et al.. Use of cyclosporin A in allotransplantation of rat limbs. Ann. Plast. Surg., 1984, 12: 249-249

[9] DoiK. Homotransplantation of limbs in rats. Plast Reconstr Surg, 1979, 64: 613-613

[10] PressB H, SibeyR K, ShonsA R. Limb allotransplantation in the rat: Extended survival and return of nerve function with continuous cyclosporine/prednisone immunosuppression. Ann Plast Surg, 1986, 16: 313-313

[11] Guzman-SteinA, ShonsA R. Functional recovery in the rat limb transplantation model: a preliminary study. Transpl Proc, 1987, 19: 1115-1115

[12] GoldwynR M, BeachM, FeldmanD, et al.. Canine limb homotransplantation. Plast Reconstr Surg, 1966, 37: 184-184

[13] KurokiH, IkutaY, AkiyamaM. Experimental studies of vascularized allogenic limb transplantation in the rat using a new immunosuppressive agent, FK506: Morphological and immunological analysis. Transpl Proc, 1989, 21: 3187-3187

[14] PressB H, SibleyR K, ShonesA R. Modification of experimental limb allograft rejection with cyclosporin and prednisone: a preliminary report. Transpl Proc., 1983, 15: 3057-3057

[15] FritzW D, SwartzW M, RoseS, et al.. Limb allografts in rats immunosuppressed with cyclosporin A. Ann Surg, 1984, 199: 211-211